TipRanks
EC Healthcare (HK:2138)
:2138
Hong Kong Market
2138
EC Healthcare
RESEARCH TOOLSreports
Want to see HK:2138 full AI Analyst Report?

EC Healthcare (2138) Ratios

1 Followers

EC Healthcare Ratios

HK:2138's free cash flow for Q4 2026 was HK$0.15. For the 2026 fiscal year, HK:2138's free cash flow was decreased by HK$ and operating cash flow was HK
gt;-0.01. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 0.91 0.91 1.00 0.92 0.85
Quick Ratio
 0.83 0.83 0.92 0.85 0.80
Cash Ratio
 0.44 0.44 0.53 0.39 0.42
Solvency Ratio
 >-0.01 0.04 0.16 0.20 0.21
Operating Cash Flow Ratio
 0.34 0.34 0.39 0.48 0.36
Short-Term Operating Cash Flow Coverage
 0.78 1.01 1.47 5.03 6.00
Net Current Asset Value
HK$ -1.03BHK$ -1.03BHK$ -940.97MHK$ -1.65BHK$ -1.72B
Leverage Ratios
Debt-to-Assets Ratio
 0.29 0.29 0.27 0.30 0.28
Debt-to-Equity Ratio
 0.91 0.91 0.75 0.82 0.83
Debt-to-Capital Ratio
 0.48 0.48 0.43 0.45 0.45
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.14 0.29 0.25
Financial Leverage Ratio
 3.14 3.14 2.80 2.74 2.97
Debt Service Coverage Ratio
 0.48 0.81 1.02 3.12 4.59
Interest Coverage Ratio
 4.13 0.48 1.06 1.08 3.44
Debt to Market Cap
 1.16 1.10 0.97 0.60 0.10
Interest Debt Per Share
 1.12 1.12 1.21 1.44 1.35
Net Debt to EBITDA
 1.18 0.90 0.55 1.41 1.05
Profitability Margins
Gross Profit Margin
22.85%15.92%80.73%84.18%85.73%
EBIT Margin
0.98%0.92%-0.28%2.80%5.16%
EBITDA Margin
11.00%14.50%14.96%17.65%20.30%
Operating Profit Margin
7.85%0.92%2.29%2.59%5.65%
Pretax Profit Margin
-10.88%-10.88%-2.44%0.40%3.51%
Net Profit Margin
-10.68%-10.68%-4.04%-0.45%1.80%
Continuous Operations Profit Margin
-10.95%-10.95%-2.70%0.37%2.76%
Net Income Per EBT
98.19%98.19%165.30%-112.29%51.15%
EBT Per EBIT
-138.58%-1185.95%-106.53%15.47%62.20%
Return on Assets (ROA)
-9.26%-9.26%-3.33%-0.35%1.26%
Return on Equity (ROE)
-25.36%-29.08%-9.32%-0.97%3.76%
Return on Capital Employed (ROCE)
11.44%1.34%3.02%2.77%5.70%
Return on Invested Capital (ROIC)
8.79%1.03%2.45%2.34%4.06%
Return on Tangible Assets
-11.79%-11.79%-4.48%-0.50%1.70%
Earnings Yield
-59.10%-73.87%-20.44%-1.23%0.94%
Efficiency Ratios
Receivables Turnover
 13.64 13.64 9.99 13.18 0.00
Payables Turnover
 35.68 38.88 7.53 8.21 7.89
Inventory Turnover
 18.99 20.69 5.23 6.22 6.36
Fixed Asset Turnover
 4.57 4.57 3.91 3.03 2.44
Asset Turnover
 0.87 0.87 0.82 0.78 0.70
Working Capital Turnover Ratio
 -14.16 -47.40 -70.43 -23.17 -78.46
Cash Conversion Cycle
 35.74 35.00 57.80 41.93 11.09
Days of Sales Outstanding
 26.75 26.75 36.52 27.68 0.00
Days of Inventory Outstanding
 19.22 17.64 69.78 58.68 57.36
Days of Payables Outstanding
 10.23 9.39 48.50 44.43 46.27
Operating Cycle
 45.97 44.39 106.30 86.36 57.36
Cash Flow Ratios
Operating Cash Flow Per Share
 0.51 0.51 0.63 0.58 0.52
Free Cash Flow Per Share
 0.51 0.51 0.58 0.45 0.17
CapEx Per Share
 0.00 0.00 0.05 0.14 0.35
Free Cash Flow to Operating Cash Flow
 1.00 1.00 0.92 0.77 0.32
Dividend Paid and CapEx Coverage Ratio
 0.00 0.00 10.77 3.18 1.15
Capital Expenditure Coverage Ratio
 0.00 0.00 13.00 4.27 1.47
Operating Cash Flow Coverage Ratio
 0.48 0.48 0.55 0.43 0.40
Operating Cash Flow to Sales Ratio
 0.16 0.16 0.18 0.16 0.16
Free Cash Flow Yield
89.76%111.26%83.89%34.26%2.65%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -1.70 -1.35 -4.93 -81.32 106.27
Price-to-Sales (P/S) Ratio
 0.18 0.14 0.20 0.37 1.91
Price-to-Book (P/B) Ratio
 0.49 0.39 0.46 0.79 3.99
Price-to-Free Cash Flow (P/FCF) Ratio
 1.11 0.90 1.19 2.92 37.80
Price-to-Operating Cash Flow Ratio
 1.12 0.90 1.10 2.24 12.17
Price-to-Earnings Growth (PEG) Ratio
 0.02 >-0.01 >-0.01 0.64 -1.63
Price-to-Fair Value
 0.49 0.39 0.46 0.79 3.99
Enterprise Value Multiple
 2.81 1.90 1.87 3.49 10.46
Enterprise Value
 1.17B 1.04B 1.16B 2.59B 8.22B
EV to EBITDA
 2.81 1.90 1.87 3.49 10.46
EV to Sales
 0.31 0.27 0.28 0.62 2.12
EV to Free Cash Flow
 1.92 1.71 1.69 4.91 42.00
EV to Operating Cash Flow
 1.92 1.71 1.56 3.76 13.52
Tangible Book Value Per Share
 0.66 0.66 0.76 0.71 0.82
Shareholders’ Equity Per Share
 1.17 1.17 1.51 1.65 1.57
Tax and Other Ratios
Effective Tax Rate
 >-0.01 >-0.01 -0.11 0.07 0.21
Revenue Per Share
 3.18 3.18 3.49 3.55 3.28
Net Income Per Share
 -0.34 -0.34 -0.14 -0.02 0.06
Tax Burden
 0.98 0.98 1.65 -1.12 0.51
Interest Burden
 -11.16 -11.86 8.65 0.14 0.68
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.08 0.00 0.10 0.05 0.06
Stock-Based Compensation to Revenue
 0.00 0.00 <0.01 <0.01 0.02
Income Quality
 -1.51 -1.51 -7.35 -36.37 8.73
Currency in HKD